Articles From: Xcel Energy Announces Redemption of 7.60% Junior Subordinated Notes, Series Due 2068 to XenoPort to Present at the Cowen and Company 33rd Annual Health Care Conference

Xcel Energy Inc. (NYSE: XEL) today announced that it has submitted a redemption notice to the trustee to redeem all of its outstanding 7.60% Junior Subordinated Notes, Series Due 2068 (CUSIP No.

WASHINGTON --Even if utilities succeed in weakening coming U.S. climate change regulations, no new coal-fired power plants are likely to be built in the U.S., according Xcel Energy Inc. (XEL) Chief Executive Ben Fowke.

Xcel Energy Inc. (NYSE: XEL) today reported 2013 first quarter earnings of $237 million, or $0.48 per share compared with 2012 earnings of $184 million, or $0.38 per share.

The Board of Directors of Xcel Energy (NYSE: XEL) today declared a quarterly dividend on its common stock of 27 cents per share.

Maintains top spot for ninth consecutive year MINNEAPOLIS , April 11, 2013 /PRNewswire/ -- Xcel Energy remains the number one utility provider of wind energy in the United States , according to a newly released report from the American Wind Energy Association.

Wind energy, efficiency programs and power plant improvements are credited MINNEAPOLIS , April 22, 2013 /PRNewswire/ -- Xcel Energy today announced a 16 percent reduction in carbon dioxide emissions, or 14 million tons, since the utility in 2005 began a reduction strategy in its eight-state service territory.

On Sunday, May 5, Xcel Energy’s (NYSE:XEL) Sr Vice President and CFO, Teresa Madden, will speak to the investment community at the AGA Financial Forum in Naples, FL at 3:00 p.m. Eastern time.

DENVER , April 10, 2013 /PRNewswire/ -- Xcel Energy announced earlier this week that it will pursue additional legal measures if Boulder, Colorado attempts to provide electric service to customers outside existing city limits.

Xcel Energy Inc. (NYSE: XEL) subsidiary Public Service Company of Colorado (PSCo) today announced that it closed an offering of $250.0 million of 2.50% first mortgage bonds due March 15, 2023 (the 2023 Bonds) and $250.0 million of 3.95% first mortgage bonds due March 15, 2043 (the 2043 Bonds). The 2023 Bonds and the 2043 Bonds are redeemable at any time subject to certain “make whole” provisions prior to September 15, 2022 and September 15, 2042, respectively.

GE’s new Evolve™ LED Scalable Cobrahead lighting fixtures have been installed by Xcel Energy in the city of West St.

On Wednesday, May 22, Xcel Energy (NYSE: XEL) will hold its annual shareholders meeting in Eau Claire, WI, at 11:00 a.m. Central Time.

Citing changed circumstances since its November 2012 application, Xcel Energy (NYSE:XEL) proposed a reduction to the electricity rate increase request currently under review before the Minnesota Public Utilities Commission.

SAN JOSE, Calif.

LONDON --

Xebec Announces 2013 First Quarter Operating Results Canada NewsWire * EBITDA is a non-IFRS financial measure and the Company defines it as earnings from operations excluding financial charges, taxes, foreign exchange loss (gain) and amortization.

Xebec Announces Net Income of $1.9 Million on 7% increased Revenues for Fiscal 2012 Canada NewsWire Xebec Fiscal 2012 Fourth Quarter and Year-end Financial Results MONTREAL , April 1, 2013 /CNW Telbec/ - Xebec Adsorption Inc. (TSX: XBC) ("Xebec"), a provider of biogas upgrading, natural gas, field gas and hydrogen purification solutions for the clean energy and crude-derived fuels displacement markets, announced today its 2012 fourth quarter operating results.

Pfizer Inc. (NYSE: PFE) announced today that the Japanese Ministry of Health, Labor and Welfare (MHLW) has approved XELJANZ ® (tofacitinib citrate) for the treatment of adults with rheumatoid arthritis (RA) who have had an inadequate response to existing therapies.

RICHMOND, Va., March 21, 2013 (GLOBE NEWSWIRE) -- Xenith Bankshares, Inc. (Nasdaq:XBKS) , parent company of Xenith Bank, a business-focused bank serving the Greater Washington D.C., Richmond, and Greater Hampton Roads, Virginia markets, today announced that two members of its board of directors will not stand for re-election, and that the board of directors has nominated a new candidate for election to the board of directors, at the company's upcoming annual meeting of shareholders scheduled for May 2, 2013.

RICHMOND, Va., Feb.

RICHMOND, Va., May 1, 2013 (GLOBE NEWSWIRE) -- Xenith Bankshares, Inc. (Nasdaq:XBKS) , parent company of Xenith Bank, a business-focused bank serving the Greater Washington, D.C., Richmond and Greater Hampton Roads, Virginia markets, today announced financial results for the quarter ended March 31, 2013.

XenoPort, Inc. (Nasdaq: XNPT) reported today that equity awards were made to eight new employees subject to the terms and conditions of the XenoPort 2010 Inducement Award Plan.

XenoPort, Inc. (Nasdaq: XNPT) reported today that equity awards were made to three new employees subject to the terms and conditions of the XenoPort 2010 Inducement Award Plan.

XenoPort, Inc. (Nasdaq: XNPT) reported today that equity awards were made to two new employees subject to the terms and conditions of the XenoPort 2010 Inducement Award Plan.

XenoPort, Inc. (Nasdaq: XNPT) reported today that equity awards were made to two new employees subject to the terms and conditions of the XenoPort 2010 Inducement Award Plan.

XenoPort, Inc. (Nasdaq: XNPT) announced today that it will present the following posters at the 65 th Annual Meeting of the American Academy of Neurology in San Diego, California: AP (arbaclofen placarbil) Spasticity An Ongoing Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects with Spasticity Due to Multiple Sclerosis Session Info: Poster Session P03: March 19, 2:00 pm - 6:30 pm PT Poster #: P03.267 The Burden of Multiple Sclerosis-Related Spasticity on Indirect Costs and Requirement for Non-Professional Care: Results of a Cross-Sectional Study in the USA Session Info: Poster Session P03: March 19, 2:00 pm - 6:30 pm PT Poster #: P03.217 Impact of Spasticity on Healthcare Resource Utilisation: Results of a Cross-Sectional Study in the USA Session

XenoPort, Inc. (Nasdaq: XNPT) announced today that shipments of Horizant ® (gabapentin enacarbil) Extended-Release Tablets to its distributor in the United States have commenced.

XenoPort, Inc. (Nasdaq: XNPT) reported today that GlaxoSmithKline (GSK), who holds commercialization rights to Horizant ® (gabapentin enacarbil) Extended-Release Tablets in the United States during a transition period ending on April 30, 2013, has experienced manufacturing delays that have resulted in a stockout of Horizant .

XenoPort, Inc. (Nasdaq: XNPT) announced today its financial results for the first quarter ended March 31, 2013.

XenoPort, Inc. (Nasdaq: XNPT) announced today its financial results for the fourth quarter and year ended December 31, 2012.

XenoPort, Inc. (Nasdaq:XNPT) announced today that it will provide access via the World Wide Web to its presentation at the Cowen and Company 33rd Annual Health Care Conference.